Press Releases
Drug-producing bacteria possible with synthetic biology breakthrough
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles, from the University of Warwick and the University of Surrey.
Light-activated cancer drugs without toxic side effects: fresh insight
Future cancer drugs that are activated by light and don’t cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, an intercontinental collaboration between the University of Warwick (UK) and Monash University (Australia).
Cancer targeted with reusable ‘stinging nettle’ treatment
Cancer cells can be destroyed more effectively and selectively with a unique new reusable treatment, activated with a substance found in stinging nettles and ants - thanks to new research by the University of Warwick.
Drug discovery could accelerate hugely with Machine Learning
Drug discovery could be significantly accelerated thanks to a new high precision machine-learning model, developed by an international collaboration of researchers, including the University of Warwick.
Warwick academic named as emerging leader in cell biology
A University of Warwick academic is to be awarded for their outstanding contribution to UK cell biology. Andrew McAinsh, professor of cell biology at Warwick Medical School is to receive the British Society for Cell Biology’s (BSCB) prestigious Hooke Medal.
New TB drugs possible with understanding of old antibiotic
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.